Printer Friendly Version View printer-friendly version
<< Back
Gilead Sciences Announces Second Quarter 2017 Dividend
Download PDF Download PDF

FOSTER CITY, Calif.--(BUSINESS WIRE)--May 2, 2017-- Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.52 per share of common stock for the second quarter of 2017. The dividend is payable on June 29, 2017, to stockholders of record at the close of business on June 16, 2017. Future dividends will be subject to Board approval.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Source: Gilead Sciences, Inc.

Investors
Gilead Sciences, Inc.
Robin Washington, 650-522-5688
Sung Lee, 650-524-7792

NASDAQ (US Dollar)
$80.91
 Stock is Up 1.51 (1.90%)
Data as of 02/23/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at the RBC Capital Markets 2018 Global Healthcare Conference

February 21, 2018 9:00 a.m. ET
Play
Fourth Quarter 2017 Gilead Sciences Earnings Conference Call

February 06, 2018 4:30 p.m. ET
Play
36th Annual J.P. Morgan Healthcare Conference

January 08, 2018 3:30 p.m. PT
Play
Credit Suisse 26th Annual Healthcare Conference

November 07, 2017 12:30 p.m. MT
Play